Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$114.26 - $136.0 $290,106 - $345,304
-2,539 Reduced 31.84%
5,435 $668,000
Q3 2023

Nov 07, 2023

SELL
$122.0 - $145.31 $534,848 - $637,039
-4,384 Reduced 35.47%
7,974 $1.03 Million
Q2 2023

Aug 10, 2023

SELL
$122.5 - $147.16 $3.56 Million - $4.28 Million
-29,066 Reduced 70.17%
12,358 $1.53 Million
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $5.33 Million - $6.39 Million
39,796 Added 2444.47%
41,424 $6.06 Million
Q4 2022

Feb 09, 2023

BUY
$129.72 - $159.85 $5,448 - $6,713
42 Added 2.65%
1,628 $259,000
Q3 2022

Nov 09, 2022

BUY
$126.59 - $161.18 $13,924 - $17,729
110 Added 7.45%
1,586 $211,000
Q2 2022

Aug 09, 2022

SELL
$141.59 - $168.66 $36,954 - $44,020
-261 Reduced 15.03%
1,476 $230,000
Q1 2022

May 06, 2022

BUY
$129.64 - $160.7 $225,184 - $279,135
1,737 New
1,737 $270,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.